Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples

September 27,2024

How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid‐based cytology: Role of TERT promoter and BRAF V600E mutation analysis - Dell'Aquila - 2021

Updates in the Pathologic Classification of Thyroid Neoplasms: A Review of the World Health Organization Classification

EphB3 protein is a potential ancillary diagnostic biomarker for thyroid cancers - ScienceDirect

Guidelines For Adult Patients With Thyroid Nodules, PDF, Medical Diagnosis

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate, BMC Cancer

IJMS, Free Full-Text

Frontiers New biomarkers: prospect for diagnosis and monitoring of thyroid disease

Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment

Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine‐needle aspiration cytology, BRAFV600E, and ultrasound elastography - Wang - 2022 - Journal of Clinical Ultrasound - Wiley Online Library

Malignancy Risk Analysis in Patients with Inadequate Fine Needle Aspiration Cytology (FNAC) of the Thyroid

Chapters Archive - Page 40 of 44 - Endotext

Thyroid Cancer: Diagnosis, Treatment and Follow-Up

Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples